Scientific Sessions 2025  /  Heart Failure Wars: Gene Therapy Strikes Back: An AHA Journals Session  /  Gene Therapy for Sarcomere Cardiomyopathies
Logo

American Heart Association

  62
  0

Final ID:

Gene Therapy for Sarcomere Cardiomyopathies

  • Seidman, Christine  ( HARVARD MEDICAL SCHOOL , Boston , Massachusetts , United States )
  • Bassel-duby, Rhonda  ( UT SOUTHWESTERN MEDICAL CENTER , Plano , Texas , United States )
  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Christine Seidman: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Merck, Board of Directors:Active (exists now) ; Advisor:Tenaya:Active (exists now) ; Advisor:Maze:Past (completed) | Rhonda Bassel-Duby: DO NOT have relevant financial relationships | Sharlene Day: DO have relevant financial relationships ; Consultant:Lexicon Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Consultant:Solid Biosciences:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Lexicon Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Heart Failure Wars: Gene Therapy Strikes Back: An AHA Journals Session

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Gene Therapy Strategies, Advantages, and Pitfalls

Helms Adam, Elliott Perry, Giacca Mauro

Gene Therapy for Neuromuscular Disorders

Mcnally Elizabeth, Zaidman Craig, Mammen Pradeep

More abstracts from these authors:
So How Do We Determine the Right Strategy for the Right Patient?

Watkins Hugh, Seidman Christine

Gene Therapy: The Next Frontier or Fool's Gold?

Seidman Christine, Watkins Hugh

You have to be authorized to contact abstract author. Please, Login
Not Available